10 Stocks Jim Cramer Discussed Including His Palantir Deep Dive

5. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders In Q2 2025: 83

Pfizer Inc. (NYSE:PFE) reported its third-quarter earnings report yesterday. The results were a solid bunch of numbers that saw the firm post $16.65 billion in revenue and $0.87 in adjusted earnings per share to beat analyst estimates of $16.58 billion and $0.63. However, even though the firm raised its full-year profit per share guidance to $3 and $3.15 per share from an earlier $2.90 to $3.10, its shares remained muted. Cramer has discussed the sentiment surrounding Pfizer Inc. (NYSE:PFE) on several occasions. He believes that the firm needs to find something major to impress investors. The CNBC TV host has also pointed out that Pfizer Inc. (NYSE:PFE)’s investors appear to be satisfied with its 7% yield. In this appearance, he discussed the firm’s earnings report and its dividend:

“Pfizer beat the numbers and people just yawned. Oh my god the group is so challenged.

“But we’re looking for that big win from Seagen. We never got it. It’s a bond. Pfizer’s a bond, it’s kind of like Shylock, you know, I’ll have my bond, no, I’d rather have my stock.”